Appili Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Appili Therapeutics Inc (Appili Therapeutics) is a bio-pharmaceutical company developing and commercializing anti-infective drugs for the treatment of infectious diseases and drug-resistant pathogens. Its pipeline products include ATI-1501, an oral suspension antibiotic liquid reformulation paired with metronidazole used for treating parasitic and anaerobic bacterial infections, including Clostridium difficile; ATI-1503, is focused on generating negamycin analogue candidates, against gram-negative pathogens including bacterial threats such as Klebsiella pneumoniae,Acinetobacter baumannii, Pseudomonas aeruginosa, and carbapenem-resistant Enterobacteriaceae (CRE). Appili Therapeutics works in collaboration with science and industry partners, governments and government agencies for in-licensing opportunities. The company has operations with offices in Mississauga and Toronto. Appili Therapeutics is headquartered in Halifax, Nova Scotia, Canada.

Appili Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Appili Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Appili Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Appili Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Appili Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Appili Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Appili Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Appili Therapeutics Raises USD3.4 Million in Financing 10
Appili Therapeutics Raises USD2.5 Million in Seed Financing Round 11
Licensing Agreements 12
Appili Therapeutics Enters into Licensing Agreement with National Research Council of Canada 12
Equity Offering 13
Appili Therapeutics Raises USD2.4 Million in Private Placement of Shares 13
Appili Therapeutics Raises USD1.6 Million in Private Placement of Shares 14
Appili Therapeutics Inc - Key Competitors 15
Appili Therapeutics Inc - Key Employees 16
Appili Therapeutics Inc - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Nov 28, 2017: Appili Therapeutics Appoints Seasoned Biotech Executive Ian C. Mortimer to its Board 18
Jul 06, 2017: Appili Therapeutics appoints new vice president of business development 19
Jan 06, 2017: Appili Therapeutics Appoints Industry Veteran Stephen Nicolle to its Board 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List Of Tables

List of Tables
Appili Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Appili Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Appili Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Appili Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Appili Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Appili Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Appili Therapeutics Raises USD3.4 Million in Financing 10
Appili Therapeutics Raises USD2.5 Million in Seed Financing Round 11
Appili Therapeutics Enters into Licensing Agreement with National Research Council of Canada 12
Appili Therapeutics Raises USD2.4 Million in Private Placement of Shares 13
Appili Therapeutics Raises USD1.6 Million in Private Placement of Shares 14
Appili Therapeutics Inc, Key Competitors 15
Appili Therapeutics Inc, Key Employees 16
Appili Therapeutics Inc, Other Locations 17

List Of Figures

List of Figures
Vulcan Materials Company, Performance Chart (2013 - 2017) 32
Vulcan Materials Company, Ratio Charts 37

Appili Therapeutics Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Appili Therapeutics Inc (Appili Therapeutics) is a bio-pharmaceutical company developing and commercializing anti-infective drugs for the treatment of infectious diseases and drug-resistant pathogens. Its pipeline products include ATI-1501, an oral

USD 250 View Report

Appili Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Appili Therapeutics Inc (Appili Therapeutics) is a bio-pharmaceutical company developing and commercializing anti-infective drugs for the treatment of infectious diseases and drug-resistant pathogens. Its pipeline products include ATI-1501, an oral

USD 250 View Report

Repros Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Repros Therapeutics Inc (Repros), formerly Zonagen Inc, a subsidiary of Allergan PLC, is a biopharmaceutical company that develops and markets drugs to treat hormonal and reproductive system disorders. The companys

USD 250 View Report

Acer Therapeutics Inc (ACER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Acer Therapeutics Inc (Acer), formerly Opexa Therapeutics Inc is a pharmaceutical company that offers acquisition, development and commercialization of therapies for patients with serious rare diseases. The company offers treatment

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available